ADDISON, Texas, June 30 /PRNewswire-FirstCall/ -- ULURU Inc. (NYSE Alternext: ULU) announced today that it has signed a licensing and supply agreement with Jiangxi Aiqilin Pharmaceuticals Group ("Aiqilin") for the marketing of Altrazeal™ in China, including Hong Kong, Macau and Taiwan.
Under t